贝伐珠单抗生物类似物（bevacizumab-awwb）在治疗早产儿视网膜病变方面是安全的

{"title":"贝伐珠单抗生物类似物（bevacizumab-awwb）在治疗早产儿视网膜病变方面是安全的","authors":"Cindy Yue‐Ying Liu, Zixin Hong, Shuan Dai, Shivanand Sheth, Shaheen Shah","doi":"10.1111/ceo.14439","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":501821,"journal":{"name":"Clinical & Experimental Ophthalmology","volume":"15 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bevacizumab biosimilar (bevacizumab‐awwb) is safe in the treatment of retinopathy of prematurity\",\"authors\":\"Cindy Yue‐Ying Liu, Zixin Hong, Shuan Dai, Shivanand Sheth, Shaheen Shah\",\"doi\":\"10.1111/ceo.14439\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":501821,\"journal\":{\"name\":\"Clinical & Experimental Ophthalmology\",\"volume\":\"15 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical & Experimental Ophthalmology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/ceo.14439\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Experimental Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/ceo.14439","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}